Synthetic CDR Variant Antibody Libraries
Precise Targeting, Cost-Effective
Home > Variant Libraries > Synthetic CDR Variant Antibody Libraries
The General Introduction of Synthetic CDR Variant Antibody Libraries
Synthetic antibody libraries are instrumental in designing, constructing, and successfully generating highly functional antibodies for various applications. These libraries feature optimized framework sequences (a robust scaffold) and controlled CDR diversity, giving them unique advantages over natural antibodies.

Synbio Technologies uses novel Trimer oligonucleotide-directed mutagenesis for codon optimization and synthesis of antibody CDR3 or all CDRs to create variant regions scFv or nanobody libraries. We have successfully delivered hundreds of high-quality, customized variant libraries. The antibody libraries, constructed with precise Trimer primers, provide technical support for antibody affinity maturation, drug target screening, specific antibody discovery, and other fields.
Highlights
  • Precisely Targeting CDRs
  • Diverse Synthetic Antibody Libraries
  • Enhanced Phage Display System
  • Efficient & Economical
Service Details
Process Details Turnaround Time
Sequence analysis and trimer oligos design Optimize framework sequence and design the amino acid composition and proportion of the CDRs. 1-2 weeks
Vector construction Sequence assembly and cloning in the antibody expression vectors. 2-3 weeks
Transform E.coli and Library construction Transform the constructs into TG1 competent cells, then prepare the plasmid and identify the capacity and accuracy of the library. 2-3 weeks
Workflow

Deliverables
Synthesized DNA fragments
Synthesized libraries cloned into vectors
Variable fragment phagemid library
FAQs
Get in Touch with Us
Related Services
  • Address:
    9 Deer Park Dr., Suite J-25
    Monmouth Junction, NJ 08852

This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you.
To find out more about the cookies we use, see our Privacy Policy.

Accept